Heart-Lung machine showdown: which oxygenator spares your platelets?
NCT ID NCT05588011
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 68 adults having planned heart surgery that required a heart-lung machine. Researchers compared two different oxygenators (artificial lungs) to see if one caused more damage to platelets, the blood cells that help stop bleeding. They used a special test called Plateletworks to measure platelet function during surgery. The goal was to learn which oxygenator is safer and improve how doctors monitor bleeding risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOPULMONARY BYPASS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Halifax Infirmary site, Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, B3H3A7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your genes predict blood thinner effectiveness?
- Calcium timing during bypass may cut need for heart drugs
- Your DNA could determine which heart drug works best
- Double nerve block may ease pain and speed recovery after heart surgery
- New dashboard aims to give surgeons a complete view during heart surgery
- Could a simple nerve block transform heart surgery recovery?